成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 98-03-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 98-03-3
Chemical Structure| 98-03-3
Structure of 98-03-3 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 98-03-3 ]

Related Doc. of [ 98-03-3 ]

Alternatived Products of [ 98-03-3 ]
Product Citations

Product Citations

Buhlak, Shafeek ; Abad, Nadeem ; Akachar, Jihane , et al. DOI:

Abstract: Background/Objectives: Glioblastoma multiforme (GBM), an aggressive and deadly brain tumour, presents significant challenges in achieving effective treatment due to its resistance to current therapies and poor prognosis. This study aimed to synthesise and evaluate 23 novel analogues of 3,4-dihydroquinolin-2(1H)-one, designed to enhance druggability and solubility, and to investigate their potential as VEGFR2 inhibitors for GBM treatment. Methods: The synthesised compounds were analysed using in silico methods, including molecular docking and dynamics studies, to assess their interactions with key residues within the VEGFR2 binding pocket. In vitro evaluations were performed on U87-MG and U138-MG GBM cell lines using MTT assays to determine the IC50 values of the compounds. Results: Among the tested compounds, 4u (IC50 = 7.96 μM), 4t (IC50 = 10.48 μM), 4m (IC50 = 4.20 μM), and 4q (IC50 = 8.00 μM) demonstrated significant antiproliferative effects against both the U87-MG and U138-MG cell lines. These compounds exhibited markedly higher efficacy compared to temozolomide (TMZ), which showed IC50 values of 92.90 μM and 93.09 μM for U87-MG and U138-MG, respectively. Molecular docking and dynamics studies confirmed strong interactions between the compounds and VEGFR2 kinase, supporting their substantial anti-cancer activity. Conclusions: This study highlights the promising potential of 3,4-dihydroquinolin-2(1H)-one analogues, particularly 4m, 4q, 4t, and 4u, as VEGFR2-targeting therapeutic agents for GBM treatment. Further detailed research is warranted to validate and expand upon these findings.

Keywords: glioblastoma multiforme ; 3,4-dihydroquinolin-2(1H)-one ; therapeutic efficacy ; molecular docking ; molecular dynamics ; VEGFA–VEGFR2 pathway ; anti-cancer

Purchased from AmBeed: ; ; ;

Product Details of [ 98-03-3 ]

CAS No. :98-03-3 MDL No. :MFCD00005429
Formula : C5H4OS Boiling Point : -
Linear Structure Formula :- InChI Key :CNUDBTRUORMMPA-UHFFFAOYSA-N
M.W : 112.15 Pubchem ID :7364
Synonyms :
Chemical Name :Thiophene-2-carbaldehyde

Calculated chemistry of [ 98-03-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 29.71
TPSA : 45.31 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.26 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.4
Log Po/w (XLOGP3) : 1.02
Log Po/w (WLOGP) : 1.56
Log Po/w (MLOGP) : 0.37
Log Po/w (SILICOS-IT) : 2.73
Consensus Log Po/w : 1.42

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.64
Solubility : 2.57 mg/ml ; 0.0229 mol/l
Class : Very soluble
Log S (Ali) : -1.56
Solubility : 3.08 mg/ml ; 0.0275 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.55
Solubility : 3.12 mg/ml ; 0.0279 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.59

Safety of [ 98-03-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H227-H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 98-03-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 98-03-3 ]
  • Downstream synthetic route of [ 98-03-3 ]

[ 98-03-3 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 98-03-3 ]
  • [ 24445-35-0 ]
Reference: [1] Tetrahedron, 1985, vol. 41, # 18, p. 3803 - 3812
  • 2
  • [ 98-03-3 ]
  • [ 238749-50-3 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1984, vol. 21, p. 215 - 217
  • 3
  • [ 98-03-3 ]
  • [ 120-92-3 ]
  • [ 176957-55-4 ]
Reference: [1] ChemMedChem, 2016, p. 1328 - 1338
[2] Russian Chemical Bulletin, 2006, vol. 55, # 7, p. 1184 - 1194
[3] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 6, p. 2623 - 2631
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 98-03-3 ]

Aldehydes

Chemical Structure| 13679-70-4

[ 13679-70-4 ]

5-Methylthiophene-2-carbaldehyde

Similarity: 0.97

Chemical Structure| 5834-16-2

[ 5834-16-2 ]

3-Methyl-2-thiophenecarboxaldehyde

Similarity: 0.82

Chemical Structure| 24445-35-0

[ 24445-35-0 ]

5-(Methylthio)thiophene-2-carbaldehyde

Similarity: 0.79

Chemical Structure| 5834-16-2

[ 5834-16-2 ]

3-Methyl-2-thiophenecarboxaldehyde

Similarity: 0.82

Chemical Structure| 5834-16-2

[ 5834-16-2 ]

3-Methyl-2-thiophenecarboxaldehyde

Similarity: 0.82

; ;